
Belgian biopharma firm UCB says it will be sponsoring a ‘Hack Epilepsy’ event this year to help support patient needs …
The global market for epilepsy treatments is expected to make a slow recovery after a wave of patent expiries from …

UCB’s sales fell 13% in 2009 as the pharma company faced the first full year of generic competition in the …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

